SCHEMBL4385872

SCHEMBL4385872

CC(C(=O)NCC(=O)O)c1cccc(C(O)c2ccccc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MME P08473 5/20 0.51
ACE P12821 3/20 0.48
ERCC1 P07992 1/20 0.46
ERCC4 Q92889 1/20 0.46
GLI1 P08151 2/20 0.44
GLI2 P10070 2/20 0.44
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA9 Q16790 1/20 0.41
ALDH1A1 P00352 4/20 0.40
MEN1 O00255 2/20 0.40
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
HTT P42858 2/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ECE1 P42892 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3147315 0.87 MME (0.51) MMEACEERCC1ERCC4GLI1
SCHEMBL6137585 0.85 MME (0.62) MMEACEERCC1ERCC4ALDH1A1
SCHEMBL3143059 0.82 GLI1 (0.65) GLI1GLI2CA12CA1CA2
SCHEMBL27598564 0.81 PTGS1 (0.65) MMEACEERCC1ERCC4GLI1
SCHEMBL1891876 0.81 PTGS1 (0.65) MMEACEERCC1ERCC4GLI1
SCHEMBL17889085 0.80 CXCL8 (0.52) GLI1GLI2CA12CA1CA2
SCHEMBL4386602 0.79 MME (0.47) MMEACEERCC1ERCC4GLI1
2-{3-[Hydroxy(Phenyl)Methyl]Phenyl}Propanoic Acid SCHEMBL8851028 0.78 PTGS1 (0.62) ALDH1A1MEN1MAPTKMT2AHPGD
2-{3-[Hydroxy(Phenyl)Methyl]Phenyl}Propanoic Acid SCHEMBL12129512 0.78 PTGS1 (0.62) ALDH1A1MEN1MAPTKMT2AHPGD
2-{3-[Hydroxy(Phenyl)Methyl]Phenyl}Propanoic Acid SCHEMBL4380095 0.78 PTGS1 (0.62) ALDH1A1MEN1MAPTKMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255726-B1 (R)-2-ARYL-PROPIONAMIDES, USEFUL IN THE INHIBITION OF IL-8 INDUCED CHEMIOTAXIS OF NEUTROPHILS DOMPE PHA R MA SPA RES & MFG (IT) 2009-11-11 EP disclosed
US-20040181073-A1 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils DOMPÉ FARMACEUTICI S.P.A. (IT) 2004-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040181073-A1 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils CXCL8, MMP8, CCR8 MME 2941/4885ACE 1844/4885ERCC1 2810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.